Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.

× No keyword cloud information.

6 in total

1. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.

Authors: M A Miller; L McCann
Journal: Health Econ Date: 2000-01 Impact factor: 3.046

2. Routine hepatitis B immunisation in India: cost-effectiveness assessment.

Authors: M A Miller; M Kane
Journal: Indian J Pediatr Date: 2000-04 Impact factor: 1.967

3. Global alliance on vaccines and immunizations. Vaccine promotion is circumventing market forces.

Authors: R K Ojha; Jacob Abraham; Meenakshi Khosla; Jacob M Puliyel
Journal: BMJ Date: 2002-04-20

4. The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation.

Authors: R R Deuson; E J Hoekstra; R Sedjo; G Bakker; P Melinkovich; D Daeke; A L Hammer; D Goldsman; F N Judson
Journal: Am J Public Health Date: 1999-11 Impact factor: 9.308

5. Epidemiology of digestive tract cancers in India. III. Liver.

Authors: V Dhir; K M Mohandas
Journal: Indian J Gastroenterol Date: 1998 Jul-Sep

6. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

Authors: J P Villeneuve; M Desrochers; C Infante-Rivard; B Willems; G Raymond; M Bourcier; J Côté; G Richer
Journal: Gastroenterology Date: 1994-04 Impact factor: 22.682

6 in total

1 in total

Review 1. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.

Authors: Samuel D Shillcutt; Damian G Walker; Catherine A Goodman; Anne J Mills
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

1 in total